Cargando…

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases

Buparvaquone (BPQ), a veterinary drug, was formulated as nanostructured lipid carriers (NLC) for leishmaniases treatment. The formulation design addressed poor water solubility of BPQ and lack of human drug delivery system. The DSC/TG and microscopy methods were used for solid lipids screening. Soft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monteiro, Lis Marie, Löbenberg, Raimar, Cotrim, Paulo Cesar, Barros de Araujo, Gabriel Lima, Bou-Chacra, Nádia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309432/ https://www.ncbi.nlm.nih.gov/pubmed/28255558 http://dx.doi.org/10.1155/2017/9781603

Ejemplares similares

Evaluation of the DDSolver Software Applications
por: Zuo, Jieyu, et al.
Publicado: (2014)

Antiulcerogenic Potential Activity of Free and Nanoencapsulated Passiflora serratodigitata L. Extracts
por: Strasser, Marc, et al.
Publicado: (2014)

Development of a Novel In Vitro Model to Study Lymphatic Uptake of Drugs via Artificial Chylomicrons
por: Yousef, Malaz, et al.
Publicado: (2023)

Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid
por: Yousef, Malaz, et al.
Publicado: (2022)

Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
por: Soni, Maheshkumar P., et al.
Publicado: (2014)

In Vitro Release Kinetics of Antituberculosis Drugs from Nanoparticles Assessed Using a Modified Dissolution Apparatus
por: Gao, Yuan, et al.
Publicado: (2013)

Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis
por: Thapa, Rinez, et al.
Publicado: (2021)

Biphasic Dissolution as an Exploratory Method during Early Drug Product Development
por: Amaral Silva, Daniela, et al.
Publicado: (2020)

Global distribution maps of the leishmaniases
por: Pigott, David M, et al.
Publicado: (2014)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance
por: Villares, Marie, et al.
Publicado: (2022)

Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice
por: Müller, Joachim, et al.
Publicado: (2015)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Leishmaniases in the European Union and Neighboring Countries
por: Berriatua, Eduardo, et al.
Publicado: (2021)

The leishmaniases in Kenya: A scoping review
por: Grifferty, Grace, et al.
Publicado: (2023)

Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis
por: Rufener, Reto, et al.
Publicado: (2018)

Exposure to ambient air causes degradation and decreased in vitro potency of buparvaquone and parvaquone
por: Hines, Siddra A., et al.
Publicado: (2020)

Development of a Mosquito Repellent Formulation Based on Nanostructured Lipid Carriers
por: Abrantes, Daniele Carvalho, et al.
Publicado: (2021)

Vaccines for the Leishmaniases: Proposals for a Research Agenda
por: Costa, Carlos Henrique Nery, et al.
Publicado: (2011)

Management of Leishmaniases in the Era of Climate Change in Morocco
por: Kholoud, Kahime, et al.
Publicado: (2018)

A Critical Overview of Interleukin 32 in Leishmaniases
por: Ribeiro-Dias, Fátima, et al.
Publicado: (2022)

Genetic characterisation of the Theileria annulata cytochrome b locus and its impact on buparvaquone resistance in bovine
por: Ali, Qasim, et al.
Publicado: (2022)

Selection of genotypes harbouring mutations in the cytochrome b gene of Theileria annulata is associated with resistance to buparvaquone
por: Hacılarlıoglu, Selin, et al.
Publicado: (2023)

Comparative genomics: From genotype to disease phenotype in the leishmaniases
por: Smith, Deborah F., et al.
Publicado: (2007)

Leishmaniases diagnosis: an update on the use of immunological and molecular tools
por: de Paiva-Cavalcanti, Milena, et al.
Publicado: (2015)

Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review
por: Grifferty, Grace, et al.
Publicado: (2021)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

Utilising a novel surveillance system to enhance field screening activities for the leishmaniases
por: Panahi, Elina, et al.
Publicado: (2020)

Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model
por: Müller, Joachim, et al.
Publicado: (2016)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

Nanostructured lipid carriers: versatile oral delivery vehicle
por: Poonia, Neelam, et al.
Publicado: (2016)

Characterization and toxicity of citral incorporated with nanostructured lipid carrier
por: Nordin, Noraini, et al.
Publicado: (2018)

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020)

Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model
por: Devel, Laurent, et al.
Publicado: (2019)

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
por: Haider, Mohamed, et al.
Publicado: (2020)

Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects
por: Shi, Feng, et al.
Publicado: (2016)

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models
por: Uebbing, Lukas, et al.
Publicado: (2017)

Leishmania tarentolae: A new frontier in the epidemiology and control of the leishmaniases
por: Mendoza‐Roldan, Jairo Alfonso, et al.
Publicado: (2022)

Sequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment Failure
por: Mhadhbi, Moez, et al.
Publicado: (2015)

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
por: Viegas, Cláudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e77fmjf3a74es6cesgm0uc0v5u